Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adult Solid Neoplasm|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Hereditary Breast and Ovarian Cancer Syndrome
Interventions: DRUG: Carboplatin|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel|OTHER: Pharmacological Study|DRUG: Veliparib
Sponsor: National Cancer Institute (NCI)